Orthogonal Redox Cofactor for Enhanced Biomanufacturing Flexibility
Tech ID: 34020 / UC Case 2024-997-0
Brief Description
Introducing a groundbreaking orthogonal redox cofactor, NMN+, to revolutionize redox reaction control in
biomanufacturing.
Full Description
This technology establishes nicotinamide mononucleotide (NMN+) as a noncanonical, orthogonal redox cofactor,
alongside engineered enzymes, to precisely modulate redox reactions independent of natural metabolic pathways.
This innovative approach enables the manipulation of NMNH:NMN+ ratios, facilitating the production of high-purity
chemicals, such as stereo-pure 2,3-butanediol, in both cell-free systems and live E. coli cells, without interference
from traditional redox systems.
Suggested uses
- Biomanufacturing of renewable chemicals and biofuels.
- Production of stereo-pure pharmaceuticals and fine chemicals.
- Development of cell-free synthetic biochemistry platforms.
- Enhanced metabolic engineering for improved yield, titer, and productivity of bioproducts.
- Customizable biocatalyst design for a wide range of industrial applications.
Advantages
- Enables precise control of redox reaction directions, decoupled from natural metabolic processes.
- Facilitates the production of high-purity, stereo-specific biochemicals.
- Offers a cost-effective alternative to traditional cofactors with enhanced stability and efficiency.
- Supports the development of orthogonal metabolic systems for improved biomanufacturing processes.
- Potential to vastly expand the range of bio-manufacturable products through flexible, efficient redox control.
Related Materials